Correlation Between Neoleukin Therapeutics and Fortress Biotech

Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neoleukin Therapeutics and Fortress Biotech, you can compare the effects of market volatilities on Neoleukin Therapeutics and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Fortress Biotech.

Diversification Opportunities for Neoleukin Therapeutics and Fortress Biotech

-0.38

Correlation Coefficient

Neoleukin Therapeutics  Fortress Biotech

Very good diversification

The 3 months correlation between Neoleukin and Fortress is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Fortress Biotech go up and down completely randomly.

Pair Corralation between Neoleukin Therapeutics and Fortress Biotech

If you would invest  194.00  in Fortress Biotech on September 16, 2024 and sell it today you would earn a total of  0.00  from holding Fortress Biotech or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.54%
Values	Daily Returns

Neoleukin Therapeutics  vs.  Fortress Biotech

Neoleukin Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neoleukin Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Neoleukin Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Fortress Biotech

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent forward indicators, Fortress Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Neoleukin Therapeutics and Fortress Biotech

The main advantage of trading using opposite Neoleukin Therapeutics and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.

The idea behind Neoleukin Therapeutics and Fortress Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.